share_log

ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.

Benzinga Real-time News ·  Jan 11, 2023 12:28
ProKidney shares were trading higher after the company announced the publication of the trial design and early data analysis from REGEN-003 in the Journal of Blood Purification.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment